Description
IGI Global Digital Product Management Technology and Practice Interdisciplinary Perspectives by Troy Strader
Digital Product Management, Technology, and Practice: Interdisciplinary Perspectives covers a wide range of digital product management issues and offers some insight into real-world practice and research findings. Experts in several disciplines from around the world offer their views on the technical, operational, and strategic challenges that face digital product managers and researchers now and in the next several decades._x000D_ Table of contents :- _x000D_
I. Experience with Heart Valve Replacement in Pediatric Patients.- 1. The durability of the St. Jude Medical (R) valve in children.- 2. A seven-year experience with the St. Jude Medical (R) heart valve.- 3. St. Jude Medical (R) cardiac valve experience in infants and children.- 4. Thromboembolic complications in pediatric patients undergoing valve replacement with the St. Jude Medical (R) prosthesis.- 5. Long-term results of valvular replacement in pediatric patients.- 6. Performance of mechanical valves in pediatric patients.- I. Discussion.- II. Heart Valve Replacement in Adults (Age 65 and Younger).- 7. Prospective randomized study of the St. Jude Medical (R), Bjoerk-Shiley (R), and Starr-Edwards (R) 6120 valve prostheses in the mitral position.- 8. Nine years experience with 1287 Carpentier-Edwards (R) porcine bioprostheses.- 9. Primary tissue failure in porcine aortic and bovine pericardial bioprostheses.- 10. Midterm follow-up of the BioImplant (TM) (Liotta) heart valve.- 11. A comparison of St. Jude Medical (R) and Carpentier-Edwards (R) xenograft valves in the mitral position.- 12. Three-dimensional visualization of velocity fields downstream of the St. Jude Medical (R) aortic valve implanted in pigs.- 13. Quality of life after valve replacement with the St. Jude Medical BioImplant (TM) heart valve: a four-year study.- 14. Cinefluoroscopic follow up of the St. Jude Medical (R) valve in the aortic position.- 15. Thromboembolism in adults with St. Jude Medical (R) valves on ticlopidine and aspirin maintenance.- 16. Midterm follow-up of the St. Jude Medical (R) heart valve.- II. Discussion.- III. Valve Replacement in the Elderly (Age 66 and Older).- 17. Combined valve and coronary artery bypass procedures in septuagenarians and octogenarians: results in 119 patients.- 18. The Ionescu-Shiley (R) xenobioprosthesis as an aortic valve substitute in patients 66 years of age and older.- 19. Valve replacement in the elderly: operative risk and early postoperative results.- 20. Aortic valve replacement in patients 75 years and over.- 21. Durabilty and long-term results of aortic valve replacement in the elderly.- III. Discussion.- IV. Considerations in Heart Valve Replacement.- 22. Mechanical or tissue valves: Factors influencing differential therapy.- 23. Comparative analysis of mechanical and bioprosthetic valves following aortic valve replacement.- 24. Technical problems in aortic valve re-replacement.- 25. Hydrodynamics of cardiac valve prostheses: Is excellence necessary?.- 26. Surgical treatment of prosthetic valve endocarditis.- 27. Performance of four different types of mechanical and two bioprosthetic valves in the tricuspid position.- 28. Comparison of reoperation and complications in double valve (mitral and aortic) implants with mechanical or biological prostheses.- 29. Quality of life in patients with mechanical heart valves: Influence of anticoagulation therapy and valve noise.- 30. Valved conduits and conduit exchange: long-term follow-up.- IV. Discussion.- V. Long-Term Clinical Follow-Up.- 31. Seven-year experience and follow-up with St. Jude Medical (R) prostheses.- 32. Durability and low thrombogenicity of the St. Jude Medical (R) heart valve: long-term follow-up.- 33. Aortic and mitral valve replacement with the St. Jude Medical (R) prosthesis: a nine-year update report.- 34. Eight-year clinical experience with the St. Jude Medical (R) cardiac prosthetic valve.- 35. Heart valve replacement with the St. Jude Medical (R) valve prosthesis: long-term experience in 743 patients receiving valve implants in Switzerland.- V. Discussion._x000D_